A phase 2/3 trial evaluates the efficacy and safety of neoadjuvant therapy with gemcitabine-oxaliplatin, lenvatinib, and ...

The content creator, 26, was diagnosed with a rare bile duct cancer nearly three years ago ...

A Rutgers-led study found that eating less protein may help slow liver cancer in people with impaired liver function. When ...

Psychologically, it's really hard knowing that we aren’t doing anything to stop the cancer growing.

Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven ...

A senior doctor tells Dawn that cancer patients had been asked to go to private clinics and hospitals as the government ...

It’s the most common ailment for this organ in the country, but treatment is limited to diet and exercise. Researchers are ...

Gastrointestinal cancer cases are expected to double worldwide by 2050, according to a multi-institutional study co-led by ...

Dan Milsten, a former UW football player and Tacoma native, has undergone a difficult three-month ordeal after being ...

Led by Zhongshan Hospital, affiliated with Fudan University, the trial involved 11 hospitals across China. Experts say the ...

The study, published on Thursday in the New England Journal of Medicine, focused on intrahepatic cholangiocarcinoma, or ICC. This type of cancer forms in the bile ducts inside the liver and is ...

Ipilimumab-nivolumab also linked with better survival but more toxicity in small study ...